Medical and Pharmaceutical Bacterial infection breath test demonstrates efficacy in rodent studies It can provide results within 10 minutes Rowan Dunne4 days ago
Medical and Pharmaceutical Guardant Health launches multi-cancer blood test in Asia through Manulife partnership Cancer remains a leading cause of death across Asia, driving demand for early screening tools Joseph Morton5 days ago
Medical and Pharmaceutical Immutep completely tanks after discontinuing lung cancer drug trial Shares dropped by 88% on Friday the 13th, leaving investors shook Rowan Dunne6 days ago
Medical and Pharmaceutical FDA clears Median Technologies lung-nodule risk assessment software The Median system reported 93.3 per cent sensitivity and 92.4 per cent specificity when identifying malignant lung nodules Joseph Morton6 days ago
Medical and Pharmaceutical bioAffinity launches 2,000-patient study for noninvasive lung cancer test The test analyzes sputum samples using flow cytometry to identify cancer-related cellular changes Joseph MortonMarch 11, 2026
Medical and Pharmaceutical Tango Therapeutics rallies after oncology drug collaboration with Erasca Researchers think combining both drugs could create stronger and longer-lasting tumor responses Joseph MortonMarch 5, 2026
Medical and Pharmaceutical Optellum breaks new ground with TGA approval for AI-powered lung nodule solution 'Radiological computer-assisted diagnostic software for lesions suspicious of cancer' is what the FDA calls it Rowan DunneMarch 5, 2026
Medical and Pharmaceutical Kairos Pharma acquires lung cancer drug assets from Celyn Therapeutics Shares surged by 16% after the deal was announced Rowan DunneMarch 2, 2026
Medical and Pharmaceutical Tempus AI builds on FDA win with Median partnership for lung cancer detection Median secured FDA 510(k) approval for eyonis LCS on Feb. 9 Rowan DunneFebruary 23, 2026
Medical and Pharmaceutical Breath Diagnostics advances pre-op pneumonia screening with FDA breakthrough designation The FDA grants Breakthrough Device status to a limited group of technologies Joseph MortonFebruary 19, 2026